Abstract

Uterine leiomyomata (UL) are the most common neoplasms of the female reproductive tract and primary cause for hysterectomy, leading to considerable morbidity and high economic burden. Here we conduct a GWAS meta-analysis in 35,474 cases and 267,505 female controls of European ancestry, identifying eight novel genome-wide significant (P < 5 × 10−8) loci, in addition to confirming 21 previously reported loci, including multiple independent signals at 10 loci. Phenotypic stratification of UL by heavy menstrual bleeding in 3409 cases and 199,171 female controls reveals genome-wide significant associations at three of the 29 UL loci: 5p15.33 (TERT), 5q35.2 (FGFR4) and 11q22.3 (ATM). Four loci identified in the meta-analysis are also associated with endometriosis risk; an epidemiological meta-analysis across 402,868 women suggests at least a doubling of risk for UL diagnosis among those with a history of endometriosis. These findings increase our understanding of genetic contribution and biology underlying UL development, and suggest overlapping genetic origins with endometriosis.

Details

Title
Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis
Author
Gallagher, C S 1 ; Mäkinen, N 2 ; Harris, H R 3 ; Rahmioglu, N 4 ; Uimari, O 5   VIAFID ORCID Logo  ; Cook, J P 6 ; Shigesi, N 7 ; Ferreira, T 8 ; Velez-Edwards, D R 9 ; Edwards, T L 10   VIAFID ORCID Logo  ; Mortlock, S 11 ; Ruhioglu, Z 2   VIAFID ORCID Logo  ; Day, F 12   VIAFID ORCID Logo  ; Becker, C M 7   VIAFID ORCID Logo  ; Karhunen, V 13 ; Martikainen, H 14 ; M-R Järvelin 15   VIAFID ORCID Logo  ; Cantor, R M 16 ; Ridker, P M 17 ; Terry, K L 18 ; Buring, J E 17 ; Gordon, S D 19   VIAFID ORCID Logo  ; Medland, S E 20   VIAFID ORCID Logo  ; Montgomery, G W 21   VIAFID ORCID Logo  ; Nyholt, D R 22   VIAFID ORCID Logo  ; Hinds, D A 23   VIAFID ORCID Logo  ; Tung, J Y 23 ; Agee, Michelle 23 ; Alipanahi, Babak 23 ; Auton, Adam 23 ; Bell, Robert K 23 ; Bryc, Katarzyna 23 ; Elson, Sarah L 23 ; Fontanillas, Pierre 23 ; Furlotte, Nicholas A 23 ; Huber, Karen E 23 ; Kleinman, Aaron 23 ; Litterman, Nadia K 23 ; McIntyre, Matthew H 23 ; Mountain, Joanna L 23 ; Noblin, Elizabeth S 23 ; Northover, Carrie A M 23 ; Pitts, Steven J 23 ; Sathirapongsasuti, J Fah 23 ; Sazonova, Olga V 23 ; Shelton, Janie F 23 ; Shringarpure, Suyash 23 ; Tian, Chao 23 ; Vacic, Vladimir 23 ; Wilson, Catherine H 23 ; Perry, J R B 12 ; Lind, P A 20   VIAFID ORCID Logo  ; Painter, J N 20 ; Martin, N G 19   VIAFID ORCID Logo  ; Morris, A P 24 ; Chasman, D I 17 ; Missmer, S A 25 ; Zondervan, K T 26   VIAFID ORCID Logo  ; Morton, C C 27   VIAFID ORCID Logo 

 Department of Genetics, Harvard Medical School, Boston, MA, USA 
 Department of Obstetrics and Gynecology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA 
 Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA 
 Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK 
 Endometriosis CaRe Centre, Nuffield Department of Women’s and Reproductive Health, University of Oxford, John Radcliffe Hospital, Oxford, UK; Department of Obstetrics and Gynecology, Oulu University Hospital and PEDEGO Research Unit & Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland 
 Department of Biostatistics, University of Liverpool, Liverpool, UK 
 Endometriosis CaRe Centre, Nuffield Department of Women’s and Reproductive Health, University of Oxford, John Radcliffe Hospital, Oxford, UK 
 Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK; Big Data Institute, Li Ka Shing Center for Health Information and Discovery, Oxford University, Oxford, UK 
 Vanderbilt Genetics Institute, Vanderbilt Epidemiology Center, Institute for Medicine and Public Health, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA 
10  Division of Epidemiology, Department of Medicine, Institute for Medicine and Public Health, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA 
11  Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia 
12  MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, UK 
13  Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland; Unit of Primary Health Care, Oulu University Hospital, Oulu, Finland; Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, UK 
14  Department of Obstetrics and Gynecology, Oulu University Hospital and PEDEGO Research Unit & Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland 
15  Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland; Unit of Primary Health Care, Oulu University Hospital, Oulu, Finland; Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, UK; Biocenter Oulu, University of Oulu, Oulu, Finland; Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, Middlesex, UK 
16  Department of Human Genetics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA 
17  Division of Preventative Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA 
18  Obstetrics and Gynecology Epidemiology Center, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA 
19  Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia 
20  Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia 
21  Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia; Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia 
22  Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, Brisbane, QLD, Australia 
23  23andMe, Mountain View, CA, USA 
24  Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK; Department of Biostatistics, University of Liverpool, Liverpool, UK 
25  Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Obstetrics, Gynecology, and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, USA 
26  Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK; Endometriosis CaRe Centre, Nuffield Department of Women’s and Reproductive Health, University of Oxford, John Radcliffe Hospital, Oxford, UK 
27  Department of Obstetrics and Gynecology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Manchester Centre for Audiology and Deafness, Manchester Academic Health Science Center, University of Manchester, Manchester, UK 
Pages
1-11
Publication year
2019
Publication date
Oct 2019
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2309520578
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.